Dr. Kenneth H. Yu

Dr. Kenneth H. Yu, MD, is a medical oncologist specializing in the treatment of pancreatic, hepatobiliary, and other gastrointestinal cancers. He practices at Memorial Sloan Kettering Cancer Center, where he combines expert clinical care with an active research program focused on advancing outcomes for patients with pancreatic and related cancers. Dr. Yu brings dedicated expertise to the multidisciplinary management of these complex malignancies, providing patients with access to the latest diagnostic approaches and emerging therapies.

His research program centers on two primary areas: the discovery and implementation of biomarkers for the early diagnosis of pancreatic cancer, and the development of more effective treatments for the disease. This work is supported by funding from the National Cancer Institute and the National Institutes of Health, as well as the Lustgarten Foundation and the Thompson Family Foundation, reflecting broad recognition of his contributions to pancreatic cancer science. Through his laboratory and clinical investigations, Dr. Yu works to translate scientific discoveries into meaningful advances in patient care.

Dr. Yu's dual focus on early detection and novel therapeutics positions him at the forefront of efforts to address one of oncology's most challenging diseases. His research program reflects a commitment to improving survival and quality of life for patients facing pancreatic cancer, combining rigorous scientific inquiry with direct clinical application. He remains an active contributor to the broader effort to understand and overcome the biological complexities that make pancreatic cancer so difficult to treat.